Is Exxsun Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Exxsun Corp (MNZO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Exxsun Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Exxsun Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Exxsun Corp?

Muslim investors may consider investing in Exxsun Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Exxsun Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Exxsun Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Exxsun Corp updated?

The Shariah compliance status of Exxsun Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Exxsun Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Exxsun Corp?

You can check the latest Shariah compliance status of Exxsun Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Exxsun Corp. Stock Analysis MNZO

United States Health Care Nano Cap

Manzo Pharmaceuticals, Inc. engages in the provision of pharmaceutical preparations services. The company is headquartered in North York, Ontario. The company went IPO on 2001-07-11. The firm also develops its lactose intolerance product, for which it holds an exclusive patent license. The firm's primary products are dietary supplements, probiotics and natural remedies. The firm's subsidiary, Manzo Pharmaceuticals LLC (Manzo), is an alternative healthcare company with patents for a probiotic remedy for lactose intolerance. The firm also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Manzo's Lacto-Freedom probiotic is a probiotic that aids in the digestion of lactose-containing foods, designed specifically for people with lactose sensitivity.

Key Statistics of Exxsun Corp (MNZO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

5000.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

937.48K

Avg. Volume

499.99K

Dividend Yield

Financial Metrics & Statements of Exxsun Corp (MNZO)

FAQ's for Exxsun Corp (MNZO)

According to Musaffa’s Shariah screening methodology, Exxsun Corp (MNZO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.